The Metoclopramide for Avoiding Pneumonia after Stroke (MAPS-2) Trial: a single-blind, randomized controlled trial of metoclopramide for the prevention of pneumonia in patients with dysphagia after an acute stroke

Registered study from NIHR funded awards. Evidence status: source reported.

Organisation

University of Nottingham

Published

2021-05-01

Source reference

NIHR130689

Jurisdiction

United Kingdom (funder)

Licence

Open Government Licence v3.0. Contains public sector information from the NIHR Open Data portal; award holders' names not imported.

Contracted organisation: University of Nottingham · Programme: Health Technology Assessment · Award: £2,416,238 · 2021-05-01 to 2027-04-30 · Status: Active · Found via: a paper's funding metadata

Source: https://fundingawards.nihr.ac.uk/award/NIHR130689. Captured 2026-10-29.

Limitations: An NIHR funding award named, by its award number, in a held paper's funding metadata. The award funded research; it does not show which data the research used.